日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma

舒尼替尼治疗老年转移性肾细胞癌患者的疗效和安全性

Hutson, T E; Bukowski, R M; Rini, B I; Gore, M E; Larkin, J M; Figlin, R A; Barrios, C H; Escudier, B; Lin, X; Fly, K; Martell, B; Matczak, E; Motzer, R J

The treatment of advanced renal cell cancer with high-dose oral thalidomide.

用高剂量口服沙利度胺治疗晚期肾细胞癌

Stebbing J, Benson C, Eisen T, Pyle L, Smalley K, Bridle H, Mak I, Sapunar F, Ahern R, Gore M E

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.

持续低剂量沙利度胺:晚期黑色素瘤、肾细胞癌、卵巢癌和乳腺癌的 II 期研究

Eisen T, Boshoff C, Mak I, Sapunar F, Vaughan M M, Pyle L, Johnston S R, Ahern R, Smith I E, Gore M E

Interferon-alpha (IFN-alpha) stimulates anti-melanoma cytotoxic T lymphocyte (CTL) generation in mixed lymphocyte tumour cultures (MLTC)

干扰素-α (IFN-α) 刺激混合淋巴细胞肿瘤培养物 (MLTC) 中抗黑色素瘤细胞毒性 T 淋巴细胞 (CTL) 的生成

Palmer, K J; Harries, M; Gore, M E; Collins, M K

IL-12 stimulation but not B7 expression increases melanoma killing by patient cytotoxic T lymphocytes (CTL)

IL-12刺激而非B7表达可增强患者细胞毒性T淋巴细胞(CTL)对黑色素瘤的杀伤作用。

De Wit, D; Flemming, C L; Harris, J D; Palmer, K J; Moore, J S; Gore, M E; Collins, M K

Sex, pregnancy, hormones, and melanoma

性、怀孕、激素和黑色素瘤

Jatoi, I; Gore, M E